Loading…
This event has ended. Create your own event on Sched.
Back To Schedule
Friday, March 2 • 7:00am - 8:00am
PO076: Prospective Multicenter Trial Of A Compounded Fixed Combination Of Latanoprost 0.005%, Dorzolamide Hydrochloride 2%, Timolol Maleate 0.5%, Brimonidine Tartrate 0.2% For Glaucoma

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
View Abstract
Speakers
LS

Friday March 2, 2018 7:00am - 8:00am EST
Astor Ballroom New York Marriott Marquis, New York, NY
  Posters, Imaging/Pharmacology/Assessment

Attendees (13)